CXBS (Corix Bioscience) Common Stock: $0.21 Mil (As of Sep. 2017)


What is Corix Bioscience Common Stock?

Corix Bioscience CXBS -99.00% Common Stock is $0.21 Mil as of Sep. 2017.

Corix Bioscience's quarterly common stock increased from Mar. 2017 ($0.00 Mil) to Jun. 2017 ($0.20 Mil) and increased from Jun. 2017 ($0.20 Mil) to Sep. 2017 ($0.21 Mil).

Corix Bioscience's annual common stock increased from Jan. 2014 ($0.00 Mil) to Jan. 2015 ($0.00 Mil) and increased from Jan. 2015 ($0.00 Mil) to Dec. 2016 ($0.10 Mil).

Corix Bioscience Common Stock Historical Data

* Premium members only.

The historical data trend for Corix Bioscience's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience Common Stock Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
Common Stock
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.10

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.10 0.00 0.20 0.21

Corix Bioscience Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.21 Mil mean?
Corix Bioscience (CXBS) has a Common Stock of $0.21 Mil as of Sep. 2017. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Corix Bioscience and its competitors.
Is Corix Bioscience's Common Stock too high?
Corix Bioscience's current Common Stock is $0.21 Mil.
How does Corix Bioscience's Common Stock compare to BKIT and YBAO?
Corix Bioscience's Common Stock of $0.21 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Corix Bioscience and its competitors. Corix Bioscience's current Common Stock is $0.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corix Bioscience stock overvalued right now?
Corix Bioscience (CXBS) has a current Common Stock of $0.21 Mil. The current Common Stock is $0.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Corix Bioscience (CXBS), the current Common Stock is $0.21 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corix Bioscience Business Description

Address 18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.